Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Nov 19, 2018 | Sale | $16.53 | 80,000 | 1,322,480 | 49,375 | Nov 21, 2018, 04:05 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jan 02, 2018 | Sale | $20.08 | 150,000 | 3,011,840 | 75,000 | Jan 04, 2018, 12:00 AM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Sep 25, 2017 | Sale | $14.01 | 40,000 | 560,440 | 20,000 | Sep 27, 2017, 04:05 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Sep 05, 2017 | Sale | $12.51 | 6,446 | 80,646 | 3,223 | Sep 07, 2017, 04:05 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Sep 06, 2017 | Sale | $12.51 | 30,334 | 379,544 | 15,167 | Sep 07, 2017, 04:05 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jul 27, 2017 | Sale | $12.51 | 1,000 | 12,511 | 500 | Jul 31, 2017, 05:50 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jul 21, 2017 | Option Exercise | $12.51 | 1,920 | 24,021 | 960 | Jul 25, 2017, 06:35 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jul 24, 2017 | Sale | $12.51 | 1,000 | 12,511 | 500 | Jul 25, 2017, 06:35 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jul 25, 2017 | Sale | $12.51 | 9,300 | 116,352 | 4,650 | Jul 25, 2017, 06:35 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Jul 03, 2017 | Option Exercise | $11.64 | 30,000 | 349,241 | 15,000 | Jul 06, 2017, 04:05 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Nov 11, 2016 | Option Exercise | $14.01 | 40,000 | 560,440 | 20,000 | Nov 15, 2016, 04:06 PM | |
AIMT | Aimmune Therapeutics, Inc. | Barrowcliffe Susan E. | General Manager, Europe | Nov 08, 2016 | Option Exercise | $11.51 | 30,000 | 345,330 | 15,000 | Nov 10, 2016, 04:05 PM |